Anosmia

LIBRARY · PHYSIOLOGY & PERCEPTION
Anosmia

The total loss of the sense of smell — the limiting case against which the entire discipline of perfumery is defined.

CATEGORY
Olfactory disorder
ONSET
Congenital or acquired
SCOPE
Total (partial: hyposmia)
STATUS
Informational — not diagnostic
QUICK ANSWER

What is anosmia?

Anosmia is the total loss of the sense of smell. It can be present from birth or follow illness, injury or neurological decline. A partial loss is called hyposmia. The word comes from Greek for without smell. In perfumery it is the limiting case, the total absence of the sense the whole discipline depends on.

01 — WHAT IT IS

What it is

Anosmia is the total loss of the sense of smell — the inability to perceive odor molecules via the olfactory receptors. It ranges from congenital, present from birth, to acquired, following illness, injury, or neurological decline, and can be partial (hyposmia) or complete.

In perfumery and fragrance evaluation, anosmia represents the limiting case: a total absence of the sensory channel the entire discipline is built around.

02 — ORIGIN OF THE TERM

Origin of the term

From the Greek an- (“without”) and osme (“smell”). Merriam-Webster dates the word’s first known use in English to 1797. Dictionary.com dates it to 1805–15.

03 — EMERGENCE DATE

Emergence date

The word dates to around 1800. I have not yet pinned down the earliest medical description of smell loss. Formal classification of olfactory disorders — anosmia, hyposmia, parosmia, phantosmia — developed through the twentieth century alongside advances in neurology and otolaryngology.

04 — RELEVANCE TO PERFUMERY

Relevance to perfumery

Anosmia has no direct application in perfumery — it is the absence against which perfumery’s premise depends. Its relevance to the field is functional rather than material: it defines the population perfumers and fragrance educators must account for, and it underlies the training protocols used both by perfumers-in-training and by patients undergoing smell rehabilitation after illness or injury.

Anyone doing serious fragrance consultation runs into it eventually — a client who has lost their sense of smell entirely and wants to understand what they are missing, or one working through structured smell training after a viral loss. Understanding the condition changes how a consultant speaks to a client with partial loss or distortion versus one with intact smell who is simply untrained.

05 — ASSOCIATED MATERIALS

Associated materials

SMELL-TRAINING SET

Not applicable in the traditional material sense. Smell training uses four reference odors: rose, eucalyptus, lemon and clove. Thomas Hummel and colleagues set out the method in The Laryngoscope in 2009. Their patients sniffed the four odors twice a day for 12 weeks.

06 — HOW ITS MEANING HAS CHANGED

How its meaning has changed

Anosmia drew far more attention after COVID-19 arrived. In April 2020 Jérôme Lechien and colleagues reported a smell disorder in 85.6 percent of 417 patients with mild-to-moderate COVID-19 in the European Archives of Oto-Rhino-Laryngology. Of those 357 patients 284 had lost smell entirely. In May 2020 Cristina Menni and Tim Spector’s team reported in Nature Medicine that 65 percent of app users who tested positive reported loss of smell and taste. This attention shifted anosmia from a niche ENT concern to a recognized quality-of-life and mental-health issue, with documented links to appetite loss, food safety risk (inability to detect spoilage or gas leaks), and depressive symptoms.

07 — ACCEPTED CLASSIFICATIONS

Accepted classifications

Congenital anosmia — present from birth, with no prior olfactory function.
Acquired anosmia — resulting from infection, trauma, chronic sinus disease, or neurodegenerative conditions.
Total vs. partial (hyposmia) — complete loss versus diminished sensitivity.
Parosmia — a related but distinct disorder where smell is present but distorted; not classified as anosmia itself but frequently discussed alongside it.
08 — CAUSES, DAILY LIFE AND COPING

Causes, daily life and coping

The US National Institute on Deafness and Other Communication Disorders (NIDCD) names the usual causes in its Smell Disorders guide. They are colds and other upper respiratory infections, sinus disease and nasal polyps, and head injury. Its older fact sheet adds hormonal disturbances, dental problems, some medicines and chemicals such as insecticides and solvents. Alzheimer’s and Parkinson’s disease can dull smell too. Some people are born without it. In Kallmann syndrome an absent or reduced sense of smell comes with delayed or absent puberty (MedlinePlus Genetics). Many people with it only learn they cannot smell when a test shows it.

Howard Hoffman and colleagues at the NIDCD added a smell test to the 2011–2012 US National Health and Nutrition Examination Survey. Among adults aged 40 and over 12.4 percent had a smell problem. 3.2 percent had anosmia or severe hyposmia, about 3.4 million people (Reviews in Endocrine and Metabolic Disorders, 2016). In 2021 Vincent Desiato and colleagues pooled studies of 175,073 people in the American Journal of Rhinology & Allergy. They found smell loss in 22.2 percent overall and 28.8 percent when smell was tested rather than self-reported (PubMed).

The first cost is safety. In March 2004 Richard Costanzo’s team at Virginia Commonwealth University reviewed 445 clinic patients. 37 percent of those with impaired smell reported at least one hazardous event against 19 percent with normal smell. Cooking accidents led the list. Spoiled food, gas leaks and fires followed (Archives of Otolaryngology–Head & Neck Surgery). In 2014 Ilona Croy, Steven Nordin and Thomas Hummel reviewed the research on quality of life in Chemical Senses. Most people with smell loss cope well. A smaller group reports a real fall in quality of life and more depression (PubMed).

What helps depends on the cause. After a virus the best-studied step is the smell training described above. When polyps or sinus disease block the nose a doctor treats that cause. At home a smoke alarm and a gas detector cover what your nose no longer warns you about. So do dates written on food in the fridge.

09 — DISPUTED AND UNCERTAIN POINTS

Disputed and uncertain points

The extent to which post-viral anosmia is reversible remains an active area of research, with outcomes varying widely by cause and individual. The reliability of smell training as a treatment protocol is generally supported but not universally consistent in results.

Anosmia’s role as an early biomarker for neurodegenerative disease — particularly Parkinson’s — is well-documented but not yet used as a standalone diagnostic tool, and its predictive value at the individual level is still debated.

11 — SOURCES

Sources

[172] Clinical and otolaryngology literature on olfactory disorders.
Lechien JR et al., “Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19),” European Archives of Oto-Rhino-Laryngology 277(8):2251–61, 2020. doi.org
Menni C et al., “Real-time tracking of self-reported symptoms to predict potential COVID-19,” Nature Medicine 26(7):1037–40, 2020.
Hummel T et al., “Effects of olfactory training in patients with olfactory loss,” The Laryngoscope 119(3):496–99, 2009. doi.org
Lechien, J. R. et al. “Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.” European Archives of Oto-Rhino-Laryngology, 2020.
Menni, C. et al. “Real-time tracking of self-reported symptoms to predict potential COVID-19.” Nature Medicine, 2020.
Merriam-Webster, “Anosmia.”
Dictionary.com, “Anosmia.”
Hummel, T. et al. “Effects of olfactory training in patients with olfactory loss.” The Laryngoscope, 2009.
NIDCD, “Smell Disorders,” National Institutes of Health. www.nidcd.nih.gov
MedlinePlus Genetics, “Kallmann syndrome,” US National Library of Medicine. medlineplus.gov
Hoffman HJ et al., “New chemosensory component in the U.S. National Health and Nutrition Examination Survey (NHANES),” Reviews in Endocrine and Metabolic Disorders, 2016. doi.org
Desiato VM et al., “The prevalence of olfactory dysfunction in the general population: a systematic review and meta-analysis,” American Journal of Rhinology & Allergy 35(2), 2021. pubmed.ncbi.nlm.nih.gov
Santos DV, Reiter ER, DiNardo LJ, Costanzo RM, “Hazardous events associated with impaired olfactory function,” Archives of Otolaryngology–Head & Neck Surgery 130(3):317–19, 2004. pubmed.ncbi.nlm.nih.gov
Croy I, Nordin S, Hummel T, “Olfactory disorders and quality of life — an updated review,” Chemical Senses 39(3):185–94, 2014. pubmed.ncbi.nlm.nih.gov

From the Library

New entries, in your inbox

I keep adding to the Library. Leave your email and I will send you what is new. You can leave any time.